Danielle Antalffy

Analysts Rick Wise and Danielle Antalffy at Leerink Swann have released an update on Medtronic, Inc. (NYSE: MDT). On Friday, Medtronic’s REVO MRI-Safe Pacing System was recommended for approval with conditions by a FDA panel. Analysts believe that this outcome was largely expected. According to...